JPMorgan Healthcare Conference Highlights: MannKind
|
|
Mannkind
|
Jan 11, 2013 10:09AM
|
Re: As Hoped, Biotech And Drugs March To Their Own Beat
|
|
Mannkind
|
Aug 07, 2012 10:28AM
|
Re: MannKind initiated with a Neutral at Cowen
|
|
Mannkind
|
Apr 13, 2012 05:58PM
|
Re: Rodman conference - 10 Sept 2012
|
|
Mannkind
|
Sep 10, 2012 11:10AM
|
Why Doesn’t MannKind Have a Partner?
|
|
Mannkind
|
Oct 07, 2012 10:22AM
|
Re: MannKind's Long And Winding Road
|
|
Mannkind
|
May 10, 2013 05:17PM
|
Re: Today's Conf Call
|
|
Mannkind
|
Apr 17, 2012 10:18AM
|
Re: From the Yahoo board
|
|
Mannkind
|
Jun 20, 2013 10:12AM
|
Re: Just a reminder
|
|
Mannkind
|
Jun 19, 2012 06:04PM
|
Re: Transcript
|
|
Mannkind
|
Aug 09, 2012 03:00PM
|
Head and Shoulders Inverse Pattern Formed (Bullish) on These Stocks on Sep-20
|
|
Mannkind
|
Sep 20, 2012 11:36AM
|
Biodel Primed To Capitalize On Next Generation Treatments In The $10B Diabetes M
|
|
Mannkind
|
Jun 18, 2013 09:02AM
|
10 Stocks That Everyone Thinks Will Explode Higher
|
|
Mannkind
|
Mar 11, 2013 10:40AM
|
Re: Short Interest released today
|
|
Mannkind
|
Apr 09, 2013 09:16PM
|
Lyxumia® is First Diabetes Therapy of its Class Approved in Japan for use in Com
|
|
Mannkind
|
Jun 28, 2013 09:03AM
|
Forbes
|
|
Mannkind
|
Jun 30, 2012 11:05PM
|
Re: 2014 call volume
|
|
Mannkind
|
Jul 02, 2012 03:09PM
|
8 Stocks Under $5 Seeing Institutional And Insider Buying
|
|
Mannkind
|
Apr 02, 2013 03:46PM
|
Re: 3 Giant Leaps for MannKind
|
|
Mannkind
|
Oct 02, 2012 12:28PM
|
Stocks to Buy: Biotechs With Binary Events
|
|
Mannkind
|
May 31, 2013 06:00PM
|